Results
|
81.
|
|
|
82.
|
|
|
83.
|
|
|
84.
|
|
|
85.
|
|
|
86.
|
|
|
87.
|
|
|
88.
|
|
|
89.
|
|
|
90.
|
|
|
91.
|
|
|
92.
|
|
|
93.
|
|
|
94.
|
|
|
95.
|
|
|
96.
|
|
|
97.
|
|
|
98.
|
Randomized phase II non-inferiority study (NO16853) of two different doses of capecitabine in combination with docetaxel for locally advanced/metastatic breast cancer. [electronic resource] by
- Buzdar, A U
- Xu, B
- Digumarti, R
- Goedhals, L
- Hu, X
- Semiglazov, V
- Cheporov, S
- Gotovkin, E
- Hoersch, S
- Rittweger, K
- Miles, D W
- O'Shaughnessy, J
- Tjulandin, S
Producer: 20120612
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
99.
|
Intensive weekly chemotherapy for good-prognosis patients with small-cell lung cancer. [electronic resource] by
- Miles, D W
- Earl, H M
- Souhami, R L
- Harper, P G
- Rudd, R
- Ash, C M
- James, L
- Trask, C W
- Tobias, J S
- Spiro, S G
Producer: 19910228
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 9
Availability: No items available.
|
|
100.
|
Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer. [electronic resource] by
- Miles, D W
- de Haas, S L
- Dirix, L Y
- Romieu, G
- Chan, A
- Pivot, X
- Tomczak, P
- Provencher, L
- Cortés, J
- Delmar, P R
- Scherer, S J
Producer: 20130521
In:
British journal of cancer vol. 108
Availability: No items available.
|